短期大剂量依替膦酸钠治疗佩吉特病中的骨软化症。
Osteomalacia in Paget's disease treated with short term, high dose sodium etidronate.
作者信息
Gibbs C J, Aaron J E, Peacock M
出版信息
Br Med J (Clin Res Ed). 1986 May 10;292(6530):1227-9. doi: 10.1136/bmj.292.6530.1227.
Abstract
Eleven patients with Paget's disease treated with sodium etidronate 20 mg/kg/day for two and four weeks showed significant reductions in plasma alkaline phosphatase activity and urinary hydroxyproline excretion, both of which are biochemical markers of bone turnover. After four weeks of treatment, however, histological examination of iliac crest biopsy samples showed that despite a rapid reduction in bone resorption there was an appreciable mineralisation defect; even after only two weeks' treatment the abnormalities in bone formation persisted for up to 10 weeks. The adverse effects of sodium etidronate on mineralisation cannot be dissociated from its beneficial effect on resorption even when it is given for short periods.
摘要
11例佩吉特病患者接受依替膦酸钠20mg/kg/天治疗2周和4周后，血浆碱性磷酸酶活性和尿羟脯氨酸排泄量均显著降低，这两者都是骨转换的生化指标。然而，治疗4周后，髂嵴活检样本的组织学检查显示，尽管骨吸收迅速减少，但仍存在明显的矿化缺陷；即使仅治疗2周，骨形成异常仍持续长达10周。即使短期使用依替膦酸钠，其对矿化的不良影响也与其对吸收的有益作用无法分开。
相似文献
1
Osteomalacia in Paget's disease treated with short term, high dose sodium etidronate.短期大剂量依替膦酸钠治疗佩吉特病中的骨软化症。
Br Med J (Clin Res Ed). 1986 May 10;292(6530):1227-9. doi: 10.1136/bmj.292.6530.1227.
2
Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease.佩吉特病中低剂量双膦酸盐治疗导致的局灶性骨软化症。
Lancet. 1984 Apr 14;1(8381):821-4. doi: 10.1016/s0140-6736(84)92272-4.
3
Effective short term treatment of Paget's disease with oral etidronate.口服依替膦酸二钠对佩吉特病的短期有效治疗
Br Med J (Clin Res Ed). 1986 Jan 11;292(6513):79-80. doi: 10.1136/bmj.292.6513.79.
4
Osteomalacia in a patient with Paget's bone disease treated with long-term etidronate.一名患有佩吉特骨病的患者长期使用依替膦酸盐治疗后出现骨软化症。
Morphologie. 2012 Aug;96(313):40-3. doi: 10.1016/j.morpho.2012.08.001. Epub 2012 Sep 27.
5
Spontaneous fractures in a patient treated with low doses of etidronic acid (disodium etidronate).一名接受低剂量依替膦酸（依替膦酸钠）治疗的患者发生自发性骨折。
Drug Saf. 1992 Mar-Apr;7(2):162-5. doi: 10.2165/00002018-199207020-00008.
6
Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone.阿仑膦酸盐与依替膦酸盐治疗骨佩吉特病的对比研究。
J Clin Endocrinol Metab. 1996 Mar;81(3):961-7. doi: 10.1210/jcem.81.3.8772558.
7
Pathologic fracture due to severe osteomalacia following low-dose diphosphonate treatment of Paget's disease of bone.低剂量双膦酸盐治疗骨Paget病后因严重骨软化症导致的病理性骨折。
Aust N Z J Med. 1983 Jun;13(3):277-9. doi: 10.1111/j.1445-5994.1983.tb04658.x.
8
Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease.长期使用依替膦酸二钠治疗骨盆佩吉特病相关的椎体严重塌陷。
Skeletal Radiol. 2000 May;29(5):279-82. doi: 10.1007/s002560050608.
9
[Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].[用依替膦酸二钠（EHDP）治疗10例有症状的佩吉特病]
Schweiz Med Wochenschr. 1976 Nov 27;106(48):1667-73.
10
Influence of disodium etidronate on Paget's disease of bone.依替膦酸二钠对骨Paget病的影响。
S Afr Med J. 1987 Oct 3;72(7):470-2.
引用本文的文献
1
Epidemiology of Paget's disease of bone in South Korea.韩国骨佩吉特病的流行病学。
JBMR Plus. 2024 Dec 28;9(3):ziae171. doi: 10.1093/jbmrpl/ziae171. eCollection 2025 Mar.
2
Novel Treatments for PXE: Targeting the Systemic and Local Drivers of Ectopic Calcification.新型 PXE 治疗方法：针对异位钙化的系统性和局部驱动因素。
Int J Mol Sci. 2023 Oct 10;24(20):15041. doi: 10.3390/ijms242015041.
3
Case report: Osteomalacia due to bisphosphonate treatment in a patient on hemodialysis.病例报告：血液透析患者双膦酸盐治疗相关性骨软化症。
BMC Nephrol. 2021 Sep 3;22(1):298. doi: 10.1186/s12882-021-02509-5.
4
Bisphosphonate Use and Fractures in Adults with Hypophosphatasia.低磷酸酯酶症成人患者中双膦酸盐的使用与骨折情况
JBMR Plus. 2019 Aug 26;3(10):e10223. doi: 10.1002/jbm4.10223. eCollection 2019 Oct.
5
Therapy for patients with CKD and low bone mineral density.慢性肾脏病及低骨密度患者的治疗。
Nat Rev Nephrol. 2013 Nov;9(11):681-92. doi: 10.1038/nrneph.2013.182. Epub 2013 Oct 8.
6
Paget's Disease of Bone: A Review of Epidemiology, Pathophysiology and Management.骨 Paget 病：流行病学、病理生理学和治疗的综述。
Ther Adv Musculoskelet Dis. 2009 Apr;1(2):107-25. doi: 10.1177/1759720X09351779.
7
Vitamin D insufficiency does not affect response of bone mineral density to alendronate.维生素 D 不足不会影响阿仑膦酸钠对骨密度的反应。
Osteoporos Int. 2009 Jul;20(7):1259-66. doi: 10.1007/s00198-008-0799-4. Epub 2008 Nov 29.
8
New bisphosphonates in the treatment of bone diseases.治疗骨病的新型双膦酸盐类药物。
Drugs Aging. 1999 Oct;15(4):285-96. doi: 10.2165/00002512-199915040-00004.
9
Alendronate treatment for osteoporosis: a review of the clinical evidence.
Osteoporos Int. 1996;6(6):419-26. doi: 10.1007/BF01629572.
10
Bisphosphonates and the treatment of bone disease in the elderly.双膦酸盐与老年骨病的治疗
Drugs Aging. 1996 Feb;8(2):113-26. doi: 10.2165/00002512-199608020-00005.
本文引用的文献
1
Measurement of the fasting urinary hydroxyproline: creatinine ratio in normal adults and its variation with age and sex.正常成年人空腹尿羟脯氨酸与肌酐比值的测定及其随年龄和性别的变化。
J Clin Pathol. 1982 Aug;35(8):807-11. doi: 10.1136/jcp.35.8.807.
2
Purification of plasma vitamin D metabolites for radioimmunoassay.
Clin Chim Acta. 1980 Dec 8;108(2):239-46. doi: 10.1016/0009-8981(80)90010-8.
3
Clinical and biochemical effects of EHDP in Paget's disease of bone: patterns of response to initial treatment and to long-term therapy.
Metab Bone Dis Relat Res. 1981;3(4-5):301-8. doi: 10.1016/0221-8747(81)90046-1.
4
Influence of a diphosphonate on the cellular aspect of young bone tissue.双膦酸盐对年轻骨组织细胞层面的影响。
Calcif Tissue Int. 1980;32(3):247-66. doi: 10.1007/BF02408548.
5
Paget's disease of bone: diagnosis and management.骨佩吉特病：诊断与管理
Metab Bone Dis Relat Res. 1981;3(4-5):219-30. doi: 10.1016/0221-8747(81)90036-9.
6
Staining of the calcification front in human bone using contrasting fluorochromes in vitro.
J Histochem Cytochem. 1984 Dec;32(12):1251-61. doi: 10.1177/32.12.6209330.
7
Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease.佩吉特病中低剂量双膦酸盐治疗导致的局灶性骨软化症。
Lancet. 1984 Apr 14;1(8381):821-4. doi: 10.1016/s0140-6736(84)92272-4.
8
Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
Q J Med. 1973 Apr;42(166):235-56.
9
Diphosphonates in Paget's disease.
Lancet. 1974 May 11;1(7863):894-8. doi: 10.1016/s0140-6736(74)90347-x.
10
Effective short term treatment of Paget's disease with oral etidronate.口服依替膦酸二钠对佩吉特病的短期有效治疗
Br Med J (Clin Res Ed). 1986 Jan 11;292(6513):79-80. doi: 10.1136/bmj.292.6513.79.
Zotero 插件